Literature DB >> 8339743

The androgen resistance syndromes: clinical and biochemical aspects.

H U Schweikert1.   

Abstract

The genetic, biochemical, clinical and endocrinological features of syndromes associated with androgen resistance (insensitivity) are described. The clinical appearance of these syndromes covers the whole spectrum of phenotypically female patients to normal appearing men with infertility. In these disorders testosterone formation and regression of the Müllerian duct derivates are normal, but male development is absent or impaired as a result of total or partial resistance to androgen action in the target cell. Based on studies with cultured genital skin fibroblasts three defects on the level of the androgen target organ can be differentiated in these syndromes: 1. Defective testosterone metabolism, 2. anomalies of the androgen receptor and 3. a postreceptor defect.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8339743     DOI: 10.1007/bf02125440

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  50 in total

1.  Hereditary male pseudohermaphroditism associated with an unstable form of 5 alpha-reductase.

Authors:  M Leshin; J E Griffin; J D Wilson
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

2.  Androgen receptor levels in preputial skin from boys with hypospadias.

Authors:  J Svensson; M Snochowski
Journal:  J Clin Endocrinol Metab       Date:  1979-09       Impact factor: 5.958

3.  Syndrome of androgen insensitivity in man: absence of 5 alpha-dihydrotestosterone binding protein in skin fibroblasts.

Authors:  B S Keenan; W J Meyer; A J Hadjian; H W Jones; C J Migeon
Journal:  J Clin Endocrinol Metab       Date:  1974-06       Impact factor: 5.958

Review 4.  Immunoassays for human müllerian inhibitory factor (MIF): new insights into the physiology of MIF.

Authors:  W L Miller
Journal:  J Clin Endocrinol Metab       Date:  1990-01       Impact factor: 5.958

5.  Qualitative receptor defects in families with androgen resistance: failure of stabilization of the fibroblast cytosol androgen receptor.

Authors:  J E Griffin; J L Durrant
Journal:  J Clin Endocrinol Metab       Date:  1982-09       Impact factor: 5.958

6.  Cloning of human androgen receptor complementary DNA and localization to the X chromosome.

Authors:  D B Lubahn; D R Joseph; P M Sullivan; H F Willard; F S French; E M Wilson
Journal:  Science       Date:  1988-04-15       Impact factor: 47.728

7.  Inhibition of androgen receptor binding by natural and synthetic steroids in cultured human genital skin fibroblasts.

Authors:  M Breiner; G Romalo; H U Schweikert
Journal:  Klin Wochenschr       Date:  1986-08-15

8.  A single nucleotide substitution introduces a premature termination codon into the androgen receptor gene of a patient with receptor-negative androgen resistance.

Authors:  M Marcelli; W D Tilley; C M Wilson; J D Wilson; J E Griffin; M J McPhaul
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

9.  Substitution of aspartic acid-686 by histidine or asparagine in the human androgen receptor leads to a functionally inactive protein with altered hormone-binding characteristics.

Authors:  C Ris-Stalpers; M A Trifiro; G G Kuiper; G Jenster; G Romalo; T Sai; H C van Rooij; M Kaufman; R L Rosenfield; S Liao
Journal:  Mol Endocrinol       Date:  1991-10

10.  Whole cell and nuclear androgen uptake in skin fibroblasts from infertile men.

Authors:  C Eil; G T Gamblin; J W Hodge; R V Clark; R J Sherins
Journal:  J Androl       Date:  1985 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.